Reliability of the OMERACT Giant cell arteritis Ultrasonography Score (OGUS): results of a patient-based exercise involving experts and non-experts in vascular ultrasonography von Duftner, Christina, Redlinger, Norbert, Bruyn, George A, Chadachan, Veerendra, Chrysidis, Stavros, Correyero, Maria, D’Agostino, Maria Antonietta, Dalsgaard Nielsen, Berit, Dasgupta, Bhaskar, De Miguel, Eugenio, Diamantopoulos, Andreas P, Fulvio, Giovanni, Gkikopoulos, Nikitas, Hartung, Wolfgang, Hocevar, Alojzija, Keen, Helen, Kurteva, Vesselina, Mandl, Peter, Manger, Eva, Mercatelli, Paolo, Midtgard, Irina, Monti, Sara, Muller, Raili, Mykkänen, Kati, Pineda, Carlos, Ponte, Cristina, Reffat, Duriad, Sarbu, Adela-Cristina, Seitz, Luca, Terslev, Lene, Schmidt, Wolfgang, Dejaco, Christian

Volltext

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-infer... von Jørgensen, Kristin K, PhD, Olsen, Inge C, PhD, Goll, Guro L, PhD, Lorentzen, Merete, MD, Bolstad, Nils, MD, Haavardsholm, Espen A, Prof, Lundin, Knut E A, Prof, Mørk, Cato, Prof, Jahnsen, Jørgen, Prof, Kvien, Tore K, Prof

Volltext

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial von Goll, G. L., Jørgensen, K. K., Sexton, J., Olsen, I. C., Bolstad, N., Haavardsholm, E. A., Lundin, K. E. A., Tveit, K. S., Lorentzen, M., Berset, I. P., Fevang, B. T. S., Kalstad, S., Ryggen, K., Warren, D. J., Klaasen, R. A., Asak, Ø., Baigh, S., Blomgren, I. M., Brenna, Ø., Bruun, T. J., Dvergsnes, K., Frigstad, S. O., Hansen, I. M., Hatten, I. S. H., Huppertz‐Hauss, G., Henriksen, M., Hoie, S. S., Krogh, J., Midtgard, I. P., Mielnik, P., Moum, B., Noraberg, G., Poyan, A., Prestegård, U., Rashid, H. U., Strand, E. K., Skjetne, K., Seeberg, K. A., Torp, R., Ystrøm, C. M., Vold, C., Zettel, C. C., Waksvik, K., Gulbrandsen, B., Hagfors, J., Mørk, C., Jahnsen, J., Kvien, T. K.

Volltext

Study protocol for the PICASSO trial: A randomized placebo-controlled trial to investigate the efficacy and safety of intraarticular steroid injections and an occupational therapy... von Gløersen, Marthe, Kjeken, Ingvild, Tveter, Anne Therese, Kazemi, Amirhossein, Sexton, Joseph, Dziedzic, Krysia, Felson, David T., Stamm, Tanja A., Guermazi, Ali, Hermann-Eriksen, Merete, Sæther, Marte Ingeborg, Lundby, Kristine, Esperø, Elisabet Langseth, Olsen, Monika, Norheim, Katrine Brække, Fister, Edle Berg, Hoff, Mari, Uleberg, Jorunn Kvalø, Midtgard, Irina Petrovna, Andreassen, Therese, Sjølie, Dag, Sletten, Heidi, Hammer, Hilde Berner, Haugen, Ida K., Hove, Åshild, Mathiessen, Alexander, Nordberg, Lena Bugge, Lillejordet, Even, Gran, Adrian, Klokkeide, Åse, Aursand, Maia Muri, Åsheim, Sofie Ryvoll, Slagsvold, Anne Lillerud, Nabizadeh, Shagaye, Karlsson, Göran, Blanck, Thalita, Nyheim, Sissel Bærø, Sjøvold, Trine Amalie

Volltext

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial von Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sexton, Joseph, Olsen, Inge Christoffer, Bolstad, Nils, Haavardsholm, Espen A, Lundin, Knut Erik Aslaksen, Tveit, Kåre Steinar, Lorentzen, Merete, Berset, Ingrid Prytz, Fevang, Bjørg-Tilde Svanes, Kalstad, Synnøve, Ryggen, Kristin, Warren, David, Klaasen, Rolf, Asak, Øivind Wessel, Baigh, Somyeh, Blomgren, Ingrid, Brenna, Øystein, Bruun, Trude J, Dvergsnes, Katrine, Frigstad, Svein Oskar, Myrnes, Inger, Hatten, Ingvild Helgheim, Huppertz-Hauss, Gert, Henriksen, Magne, Hoie, Sunniva S, Krogh, Jan Reidar, Midtgard, Irina P, Mielnik, Pawel, Moum, Bjørn, Noraberg, Geir, Poyan, Armin, Prestegård, Ulf, Rashid, Haroon Ur, Strand, Eldri Kveine, Skjetne, Kristine, Seeberg, Kathrine, Torp, Roald, Ystrøm, Carl Magnus, Vold, Cecilia, Zettel, Camilla C, Waksvik, Kenneth, Gulbrandsen, Bjørn, Hagfors, Jon, Mørk, Cato, Jahnsen, Jørgen, Kvien, Tore Kristian

Volltext bestellen

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: Open‐label extension of the NOR‐SWITCH trial von Goll, Guro Løvik, Jørgensen, Kristin Kaasen, Sexton, Joseph, Olsen, Inge Christoffer, Bolstad, Nils, Haavardsholm, Espen A, Lundin, Knut Erik Aslaksen, Tveit, Kåre Steinar, Lorentzen, Merete, Berset, Ingrid Prytz, Fevang, Bjørg-Tilde Svanes, Kalstad, Synnøve, Ryggen, Kristin, Warren, David, Klaasen, Rolf, Asak, Øivind Wessel, Baigh, Somyeh, Blomgren, Ingrid, Brenna, Øystein, Bruun, Trude J, Dvergsnes, Katrine, Frigstad, Svein Oskar, Myrnes, Inger, Hatten, Ingvild Helgheim, Huppertz-Hauss, Gert, Henriksen, Magne, Hoie, Sunniva S, Krogh, Jan Reidar, Midtgard, Irina P, Mielnik, Pawel, Moum, Bjørn, Noraberg, Geir, Poyan, Armin, Prestegård, Ulf, Rashid, Haroon Ur, Strand, Eldri Kveine, Skjetne, Kristine, Seeberg, Kathrine, Torp, Roald, Ystrøm, Carl Magnus, Vold, Cecilia, Zettel, Camilla C, Waksvik, Kenneth, Gulbrandsen, Bjørn, Hagfors, Jon, Mørk, Cato, Jahnsen, Jørgen, Kvien, Tore Kristian

Volltext bestellen